Regenerex Pharma (RGPX) Other Non Operating Income (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Other Non Operating Income data on file, last reported at -$539.0 in Q3 2025.

• Other Non Operating Income for Q3 2025 came in at -$539.0, up 89.29% year-over-year; the trailing twelve-month figure through Sep 2025 was -$7609.0 (down 277.86% YoY), and the FY2025 annual result was $5728.0, up 117.3% from the prior year.
• Other Non Operating Income grew to -$539.0 in Q3 2025 per RGPX's latest filing, from -$6092.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $19675.0 in Q3 2022 and troughed at -$6895.0 in Q2 2023.
• A 5-year average of $994.06 and a median of -$1238.5 in 2021 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income surged 1737.59% in 2024, then plunged 250.31% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at -$1889.0 in 2021, then plunged by 61.83% to -$3057.0 in 2022, then slumped by 43.05% to -$4373.0 in 2023, then fell by 15.05% to -$5031.0 in 2024, then surged by 89.29% to -$539.0 in 2025.
• Business Quant data shows RGPX's Other Non Operating Income at -$539.0 in Q3 2025, -$6092.0 in Q2 2025, and -$5031.0 in Q3 2024.